Viking Therapeutics: Pharma Stock Soars on Positive Earnings

Viking Therapeutics Today VKTX Viking Therapeutics $69.04 +18.63 (+36.96%) 52-Week Range $8.28 ▼ $99.41 Price Target $111.56 Add to Watchlist Viking Therapeutics NASDAQ: VKTX is a clinical-stage biopharmaceutical company known for its focus on developing novel treatments for metabolic and endocrine disorders. Viking Therapeutics' earnings report for the second quarter of 2024 was impressive, capturing the attention of investors and the Viking Therapeutics' analyst community. Following the release of its ear ...